X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (445) 445
Publication (32) 32
Book / eBook (14) 14
Book Chapter (9) 9
Book Review (7) 7
Conference Proceeding (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (410) 410
female (399) 399
index medicus (210) 210
middle aged (172) 172
adult (163) 163
aged (150) 150
oncology (134) 134
vulvar neoplasms - pathology (115) 115
cancer (109) 109
vulvar neoplasms - surgery (96) 96
obstetrics & gynecology (93) 93
vulvar cancer (92) 92
human papillomavirus (91) 91
cervical cancer (81) 81
aged, 80 and over (75) 75
vulvar neoplasms - prevention & control (72) 72
squamous-cell carcinoma (71) 71
vulvar neoplasms - virology (68) 68
vulvar neoplasms - epidemiology (66) 66
risk factors (64) 64
papillomavirus infections - prevention & control (62) 62
male (61) 61
adolescent (60) 60
women (58) 58
papillomavirus infections (53) 53
incidence (52) 52
prevention (51) 51
vulvar neoplasms - therapy (51) 51
uterine cervical neoplasms - prevention & control (50) 50
papillomavirus infections - epidemiology (48) 48
vulvar intraepithelial neoplasia (48) 48
carcinoma, squamous cell - pathology (47) 47
papillomavirus infections - complications (47) 47
intraepithelial neoplasia (46) 46
retrospective studies (45) 45
treatment outcome (45) 45
carcinoma (44) 44
vaccination (44) 44
vulvar neoplasms - diagnosis (44) 44
prognosis (42) 42
surgery (41) 41
hpv (40) 40
papillomavirus infections - virology (40) 40
uterine cervical neoplasms - epidemiology (40) 40
neoplasm staging (39) 39
uterine cervical neoplasms - virology (39) 39
young adult (39) 39
vulva (37) 37
human-papillomavirus (35) 35
diagnosis (34) 34
abridged index medicus (33) 33
prevalence (33) 33
vaccines (32) 32
care and treatment (31) 31
lesions (31) 31
management (30) 30
neoplasm recurrence, local - prevention & control (30) 30
vulva - pathology (30) 30
cervical-cancer (29) 29
obstetrics and gynecology (29) 29
research (29) 29
risk (29) 29
carcinoma, squamous cell - surgery (28) 28
follow-up studies (28) 28
papillomavirus vaccines - administration & dosage (28) 28
health aspects (27) 27
vaginal neoplasms - prevention & control (27) 27
vaginal neoplasms - virology (27) 27
vulvar neoplasms (26) 26
age factors (25) 25
anus neoplasms - epidemiology (25) 25
anus neoplasms - virology (25) 25
carcinoma in situ - pathology (25) 25
infection (25) 25
vaginal neoplasms - epidemiology (25) 25
hematology, oncology and palliative medicine (24) 24
medicine, general & internal (24) 24
public, environmental & occupational health (24) 24
united states - epidemiology (24) 24
vulvar neoplasms - etiology (24) 24
lymphatic metastasis (23) 23
natural-history (23) 23
vulvar neoplasms - mortality (23) 23
anal cancer (22) 22
analysis (22) 22
lymph node excision (22) 22
medical research (22) 22
epidemiology (21) 21
genital cancers (21) 21
human-papillomavirus infection (21) 21
immunology (21) 21
medicine, research & experimental (21) 21
papillomavirus vaccines - immunology (21) 21
papillomavirus vaccines - therapeutic use (21) 21
united-states (21) 21
vagina (21) 21
vulvar diseases (21) 21
vulvar neoplasms - radiotherapy (21) 21
womens health (21) 21
article (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (420) 420
German (19) 19
Polish (6) 6
French (5) 5
Bulgarian (3) 3
Italian (3) 3
Spanish (3) 3
Chinese (2) 2
Dutch (2) 2
Portuguese (2) 2
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2015, Volume 107, Issue 6, p. djv086
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2012, Volume 131, Issue 9, pp. 1969 - 1982
The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)‐related morbidity, as well as the evidence and potential practice... 
genital warts | screening | penile cancer | head and neck cancer | vulvar cancer | human papillomavirus | mortality | anal cancer | cervical cancer | incidence | HPV | vaccination | UNITED-STATES | VACCINE | LESIONS | WOMEN | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | VULVAR INTRAEPITHELIAL NEOPLASIA | INVASIVE CERVICAL-CANCER | BURDEN | HUMAN-PAPILLOMAVIRUS INFECTION | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Secondary Prevention | Papillomavirus Infections - therapy | Penile Neoplasms - epidemiology | Papillomaviridae - immunology | Vulvar Neoplasms - therapy | Head and Neck Neoplasms - epidemiology | Anus Neoplasms - therapy | Female | Anus Neoplasms - epidemiology | Uterine Cervical Neoplasms - therapy | Penile Neoplasms - therapy | Head and Neck Neoplasms - prevention & control | Papillomavirus Infections - complications | Primary Prevention | Early Detection of Cancer | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Head and Neck Neoplasms - therapy | Uterine Cervical Neoplasms - prevention & control | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Papillomavirus Vaccines - immunology | Medical colleges | Care and treatment | Vaccination | Oncology, Experimental | Research | College teachers | Prevention | Warts | Australians | Algorithms | Papillomavirus infections | Cervical cancer | Public health | Cancer | Human papillomavirus | Immunization | Infections | Disease | Medical screening | head & neck cancer
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 13, pp. 1732 - 1741
Abstract Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and help to reduce other HPV-related cancers. We aimed to... 
Hematology, Oncology and Palliative Medicine | Papillomavirus vaccines | Human papillomavirus | Vulvar neoplasms | Vaginal neoplasms | Uterine cervical neoplasms | Precancerous conditions | Anus neoplasms | GLOBAL BURDEN | INFECTIONS | Uterine cervical neo-plasms | VACCINE | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | WORLDWIDE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | INVASIVE CERVICAL-CANCER | VULVA | Predictive Value of Tests | Age Distribution | Age Factors | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Papillomaviridae - genetics | Papillomavirus Infections - diagnosis | Uterine Cervical Dysplasia - diagnosis | Young Adult | Papillomaviridae - immunology | Uterine Cervical Dysplasia - virology | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Adult | Female | Papillomavirus Infections - virology | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Cervical Neoplasms - diagnosis | Cross-Sectional Studies | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Vulvar Neoplasms - virology | Uterine Cervical Dysplasia - prevention & control | Vaginal Neoplasms - virology | Cervical Intraepithelial Neoplasia - virology | Anus Neoplasms - diagnosis | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Vulvar Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Aged | Human Papillomavirus DNA Tests | DNA, Viral - genetics | Vaginal Neoplasms - diagnosis | Papillomaviruses | Genetic aspects | Papillomavirus infections | Cervical cancer
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 7, pp. H1 - H31
Highlights • HPV is globally prevalent and related to at least 6 different cancer sites in women and men • Prevention of HPV infections and its consequences is... 
Allergy and Immunology | Prevention | Screening | HPV testing | Penile cancer | HPV vaccination | Anal cancer | Oropharyngeal cancer | Vulvar cancer | Cervical cancer | HPV | Vaginal cancer | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | PREVENTION | CERVICAL-CANCER | IMMUNOLOGY | WORLD | VACCINES | Early Detection of Cancer - methods | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Papillomavirus Infections - diagnosis | Penile Neoplasms - epidemiology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - etiology | Papillomavirus Infections - complications | Global Health | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Oropharyngeal Neoplasms - etiology | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - etiology | Vulvar Neoplasms - etiology | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Anus Neoplasms - etiology | Molecular genetics | Vaccination | Diagnosis | Papillomavirus infections | Cells | Public health | Cancer | Infection control
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 5, pp. F123 - F138
Highlights ► The analyses of human papilloma virus/virus-like particle vaccine phase III efficacy trials in young women are largely completed. ► High efficacy... 
Allergy and Immunology | Prophylactic vaccine | Genital warts | Virus-like particle | Gardasil | Clinical trials | VaIN | CIN | VIN | Cervical cancer | HPV | Cervarix | Vain | Cin | Vin | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | Cervarix (R) | (HPV)-16/18 AS04-ADJUVANTED VACCINE | OF-STUDY ANALYSIS | Gardasil (R) | CERVICAL-CANCER | IMMUNOLOGY | GRADE 3 | IMMUNOGENICITY | PARTICLE VACCINE | DOUBLE-BLIND | POOLED ANALYSIS | YOUNG-WOMEN | HPV TYPES | Vaccines, Virus-Like Particle - adverse effects | Papillomavirus Infections - complications | Humans | Condylomata Acuminata - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Vaginal Neoplasms - virology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Clinical Trials, Phase III as Topic | Vaccines, Virus-Like Particle - administration & dosage | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Papillomavirus Vaccines - adverse effects | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Vaccines - immunology | Vaccines, Virus-Like Particle - immunology | Papillomavirus Vaccines - administration & dosage | Dysplasia | Care and treatment | Oncology, Experimental | Vaccines | Research | Papillomaviruses | Warts | Health aspects | Papillomavirus infections | Public health | Cancer | Human papillomavirus
Journal Article